Cilengitide trifluoroacetate

Catalog No. A12371

Cilengitide trifluoroacetate是一种具有潜在抗肿瘤活性的环状精氨酸-甘氨酸-天冬氨酸肽。西仑吉肽结合并抑制α(v)β(3)和α(v)β(5)整联蛋白的活性,从而抑制内皮细胞-细胞相互作用、内皮细胞-基质相互作用和血管生成。
  • Yi Han Tan, .et al. Complement-activated vitronectin enhances the invasion of nonphagocytic cells by bacterial pathogens Burkholderia and Klebsiella, Cell Microbiol, 2017, Aug;19(8) PMID: 28186697
Catalog Num A12371
M. Wt 702.7
Formula C29H41N8O9F3
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 199807-35-7
Synonyms EMD 12197,EMD-85189,EMD-121974,NSC-707544,D03497
SMILES CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)Cc2ccccc2)CC(=O)O)CCCNC(=N)N.C(=O)(C(F)(F)F)O
Cilengitide trifluoroacetate是一种具有潜在抗肿瘤活性的环状精氨酸-甘氨酸-天冬氨酸肽。西仑吉肽结合并抑制α(v)β(3)和α(v)β(5)整联蛋白的活性,从而抑制内皮细胞-细胞相互作用、内皮细胞-基质相互作用和血管生成。
Targets
αvβ3 receptor (Cell-free assay) αvβ5 receptor (Cell-free assay)
4.1 nM79 nM
In vitro DMSO 89 mg/mL (126.66 mM)
Water 7 mg/mL (9.96 mM)
Ethanol Insoluble
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 14.23 mL 71.15 mL 142.31 mL
0.5 mM 2.85 mL 14.23 mL 28.46 mL
1 mM 1.42 mL 7.12 mL 14.23 mL
5 mM 0.28 mL 1.42 mL 2.85 mL

*The above data is based on the productmolecular weight 702.7. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.